Chrissobolis Sophocles, Ziogas James, Anderson Colin R, Chu Yi, Faraci Frank M, Sobey Christopher G
Department of Pharmacology, The University of Melbourne, Parkville, Victoria, Australia.
Hypertension. 2002 Apr;39(4):880-5. doi: 10.1161/01.hyp.0000013056.74554.ce.
Potassium ion (K+) normally causes cerebral vasodilatation by activating inwardly rectifying K+ (K(IR)) channels. We tested whether chronic hypertension affects the magnitude and/or mechanism of K+-induced cerebral vasodilatation in vivo. Basilar artery responses were examined in anesthetized Wistar-Kyoto (WKY; mean arterial pressure, 114+/-4 mm Hg) and spontaneously hypertensive (SHR; 176+/-3 mm Hg) rats. In WKY, elevating cerebrospinal fluid K+ concentration from 3 mmol/L to 5 and 10 mmol/L caused vasodilatation (percent maximum, 12+/-1 and 48+/-7, respectively). The response to 5 mmol/L K+ was greater in SHR (percent maximum, 17+/-2 [P<0.05 versus WKY] and 49+/-4). The K(IR) channel inhibitor, barium ion (Ba2+, 100 micromol/L) selectively inhibited dilator responses to 5 and 10 mmol/L K+ by approximately 75% in WKY. In SHR, Ba2+ had no effect on the response to 5 mmol/L K+, and only partially inhibited (by approximately 40%) the response to 10 mmol/L K+. The nonselective NO synthase (NOS) inhibitor N(omega)-nitro-L-arginine methyl ester, the neuronal NOS (nNOS) inhibitor 1-(2-trifluromethyl-phenyl)imidazole, and the N-type calcium channel inhibitor omega-conotoxin GVIA, were all without effect in WKY, but markedly inhibited the response to 5 mmol/L K+ in SHR. When applied together with Ba2+, each of these inhibitors also profoundly reduced responses to 10 mmol/L K+ in SHR. Immunostaining of basilar arteries revealed that the perivascular nNOS-containing nerve plexus was denser in SHR. Thus, K+ dilates the normotensive basilar artery predominantly via K(IR) channel activation. During chronic hypertension, small physiological elevations in K+ dilate the basilar artery by an nNOS-dependent mechanism that appears to be upregulated in a compensatory manner.
钾离子(K+)通常通过激活内向整流钾通道(K(IR))引起脑血管舒张。我们测试了慢性高血压是否会影响体内K+诱导的脑血管舒张的程度和/或机制。在麻醉的Wistar-Kyoto(WKY;平均动脉压,114±4 mmHg)和自发性高血压(SHR;176±3 mmHg)大鼠中检查基底动脉反应。在WKY中,将脑脊液K+浓度从3 mmol/L提高到5 mmol/L和10 mmol/L会引起血管舒张(最大百分比分别为12±1和48±7)。SHR对5 mmol/L K+的反应更大(最大百分比为17±2 [与WKY相比,P<0.05] 和49±4)。K(IR)通道抑制剂钡离子(Ba2+,100 μmol/L)在WKY中选择性地抑制了对5 mmol/L和10 mmol/L K+的舒张反应约75%。在SHR中,Ba2+对5 mmol/L K+的反应没有影响,仅部分抑制(约40%)对10 mmol/L K+的反应。非选择性一氧化氮合酶(NOS)抑制剂N(ω)-硝基-L-精氨酸甲酯、神经元NOS(nNOS)抑制剂1-(2-三氟甲基-苯基)咪唑和N型钙通道抑制剂ω-芋螺毒素GVIA在WKY中均无作用,但在SHR中显著抑制了对5 mmol/L K+的反应。当与Ba2+一起应用时,这些抑制剂中的每一种也都显著降低了SHR中对10 mmol/L K+的反应。基底动脉的免疫染色显示,SHR中含nNOS的血管周围神经丛更密集。因此,K+主要通过K(IR)通道激活使正常血压的基底动脉舒张。在慢性高血压期间,K+的小幅度生理性升高通过一种nNOS依赖的机制使基底动脉舒张,这种机制似乎以一种代偿性方式上调。